SCHEMBL26034846

SCHEMBL26034846

CCc1ccc(NC(=O)c2ccc(NS(C)(=O)=O)cc2Cl)cc1-c1ccccn1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
USP28 Q96RU2 3/20 0.64
DRD3 P35462 2/20 0.64
HTR2B P41595 2/20 0.64
ALB P02768 1/20 0.64
HTR1A P08908 1/20 0.64
SLC6A2 P23975 1/20 0.64
PDE4A P27815 1/20 0.64
OPRM1 P35372 1/20 0.64
SLC6A3 Q01959 1/20 0.64
PDE4D Q08499 1/20 0.64
SHH Q15465 1/20 0.64
SLC29A1 Q99808 1/20 0.64
SMO Q99835 1/20 0.64
ABCG2 Q9UNQ0 1/20 0.64
GPR39 O43194 1/20 0.49
ADRB2 P07550 1/20 0.49
ADRA2C P18825 1/20 0.49
HTR2A P28223 1/20 0.49
HTR2C P28335 1/20 0.49
TSPO P30536 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1018253 0.90 USP28 (0.78) USP28DRD3HTR2BALBHTR1A
SCHEMBL26037383 0.88 DRD3 (0.66) USP28DRD3HTR2BALBHTR1A
SCHEMBL26034829 0.86 USP28 (0.68) USP28DRD3HTR2BALBHTR1A
SCHEMBL1016563 0.84 USP28 (0.72) USP28DRD3HTR2BALBHTR1A
SCHEMBL26036530 0.83 ALB (0.56) USP28DRD3HTR2BALBHTR1A
SCHEMBL26034679 0.79 ALB (0.45) USP28DRD3HTR2BALBHTR1A
SCHEMBL1018114 0.78 USP28 (0.81) USP28DRD3HTR2BALBHTR1A
Vismodegib SCHEMBL302587 0.78 USP28 (1.00) USP28DRD3HTR2BALBHTR1A
Vismodegib SCHEMBL29363748 0.78 USP28 (1.00) USP28DRD3HTR2BALBHTR1A
Vismodegib SCHEMBL29352323 0.78 USP28 (1.00) USP28DRD3HTR2BALBHTR1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING GENENTECH, INC. (US) 2023-08-24 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230265054-A1 PYRIDYL INHIBITORS OF HEDGEHOG SIGNALLING SHH, GLI1, SMO USP28 3306/4885DRD3 3139/4885HTR2B 2106/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.